1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porter’s Five Force Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
4.6. Forward Proxy
5. DENGUE VACCINE MARKET BY VACCINE TYPE
5.1. Introduction
5.2. Live attenuated vaccines
5.3. Chimeric live attenuated vaccines
5.4. Inactivated vaccines
5.5. Subunit vaccines
5.6. Nucleic acid-based vaccines
6. DENGUE VACCINE MARKET BY PRODUCT
6.1. Introduction
6.2. CYT-TDV (Dengvaxia)
6.3. TV003/TV005
6.4. TAK-003 (DENVax)
6.5. Others
7. DENGUE VACCINE MARKET BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Subcutaneous
7.3. Oral
7.4. Others
8. DENGUE VACCINE MARKET BY END-USERS
8.1. Introduction
8.2. Hospitals
8.3. Government Institutes
8.4. Non-governmental Organizations (NGOs)
8.5. Others
9. DENGUE VACCINE MARKET BY DISTRIBUTION CHANNEL
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. DENGUE VACCINE MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. USA
10.2.2. Canada
10.2.3. Mexico
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Others
10.4. Europe
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Others
10.5. Middle East and Africa
10.5.1. Saudi Arabia
10.5.2. UAE
10.5.3. Others
10.6. Asia Pacific
10.6.1. China
10.6.2. Japan
10.6.3. South Korea
10.6.4. India
10.6.5. Indonesia
10.6.6. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
12. COMPANY PROFILES
12.1. Sanofi Pasteur Limited
12.2. Takeda Pharmaceuticals Company Limited
12.3. Butantan Institute
12.4. National Institute of Allergy and Infectious Diseases (NIAID)
12.5. Sun Pharma Industries Ltd
12.6. Merck Co. & Inc.
12.7. Inovio Pharmaceuticals
12.8. Panacea Biotec Limited
12.9. Medigen Vaccine Biologics Corporation